Adh Vasopressin
Adh Vasopressin - Related Videos
08:44
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
0 Views •
Cited by 4 •
2016
Our studies have revealed that the beneficial effects of conivaptan are dependent on the method of delivery after experimental stroke in mice. We have developed a research protocol for delivery of the receptor blocker via IV catheter on stroke-evoked brain edema formation in mice.
01:33
Hormonal Regulation
0 Views •
2019
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
03:16
Intravenous Delivery of Receptor Blockers to Reduce Brain Edema in a Mouse Model
0 Views •
2025
Source: Zeynalov, E. et. al., Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema. J. Vis. Exp. (2016)This video demonstrates the intravenous delivery of an arginine-vasopressin (AVP) receptor antagonist in a mouse model. Transient middle cerebral artery occlusion induces brain edema. An AVP receptor antagonist is administered through a catheter in the left jugular vein, alleviating edema.
07:59
Using a Comparative Species Approach to Investigate the Neurobiology of Paternal Responses
0 Views •
Cited by 2 •
2011
The comparative species approach allows behavioral neuroscientists to explore various neurobiological factors associated with specific behaviors viewed as characteristic of a specific animal model. Taking advantage of naturally occurring differences in behavior between closely related species, this technique doesn’t require invasive techniques to manipulate the expression of the behavior.
05:21
Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri
0 Views •
2025
Here, we introduce a novel approach-Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri. A laparoscopic extracorporeal knot-pusher is used to perform cervical cerclage, achieving complete occlusion of uterine arteries. Thereafter, the corpus uteri are excised to enhance visibility and facilitate the operative field.
FAQs
Binding at V2 receptors initiates a signaling response in kidney collecting-duct cells that increases aquaporin-2 channels, allowing more water to move back into the body. This reduces water loss and produces more concentrated urine. The mechanism links receptor activation to a measurable renal outcome, making collecting-duct water handling central to studying fluid homeostasis.
V1 and V2 receptors produce distinct effects because they act in different physiological contexts. V2 receptor activation supports water conservation in the kidney, whereas higher ADH vasopressin concentrations activate V1 receptors and promote vasoconstriction. This concentration-dependent shift connects fluid regulation with blood-pressure control and explains why the hormone can influence both renal and vascular outcomes.
Production and release are coordinated across two parts of the nervous and endocrine systems. ADH vasopressin is synthesized in the hypothalamus but released from the posterior pituitary, allowing hypothalamic control to produce a hormonal signal in the circulation. This arrangement illustrates how neural regulation can direct endocrine effects on distant targets such as the kidney and blood vessels.
ADH vasopressin provides a framework for examining diabetes insipidus because its signaling pathway connects hormone action with renal water handling. Researchers can focus on the sequence from hormone release to V2-receptor activation and aquaporin-2 response, then relate that pathway to the ability to retain water and concentrate urine. This approach links disease context with specific biological mechanisms.
Studying inappropriate ADH secretion highlights how dysregulated hormonal signaling can affect the same water-balance system. Analysis can follow ADH vasopressin from hypothalamic synthesis and posterior-pituitary release to receptor-mediated effects in collecting-duct cells. This context helps interpret changes in water retention and urine concentration within the broader study of endocrine physiology.
Treatments that modify ADH vasopressin signaling can be considered according to the outcome being targeted: water retention through the kidney or vascular tone through blood-vessel effects. The V2 and V1 pathways provide a biological framework for understanding strategies that alter fluid balance or vasoconstriction, while linking treatment goals to receptor-specific physiology.